Table 5 Age-specific comparison of standard gamble utility scores converted using the ‘lifetime duration-early stage cervical cancer’ score
From: A survey of population-based utility scores for cervical cancer prevention
Health state | Age groups | Wilcoxan rank sum test P value | |||
|---|---|---|---|---|---|
20-49 years | 50-69 years | ||||
Mean utility score | Median utility score | Mean utility score | Median utility score | ||
(SE) | (IQR) | (SE) | (IQR) | ||
Cyto normal | 0.9996 | 1.0 | 0.9994 | 0.9999 | 0.9255 |
(0.0002) | (0.9997 -1.0) | (0.0003) | (0.9998 -1.0) | ||
HPV vaccination | 0.9998 | 1.0 | 0.9960 | 1.0 | 0.8408 |
(<0.0000) | (0.9998 - 1.0) | (0.0034) | (0.9998 - 1.0) | ||
LG cyto | 0.9996 | 1.0 | 0.9965 | 1.0 | 0.8174 |
(0.0002) | (0.9997 -1.0) | (0.0032) | (1.0 -1.0) | ||
LG cyto with colp normal | 0.9985 | 0.9999 | 0.9956 | 0.9999 | 0.8933 |
(0.0086) | (0.9996 - 1.0) | (0.0032) | (0.9997 - 1.0) | ||
HPV positive with cyto normal | 0.9986 | 0.9999 | 0.9956 | 0.9999 | 0.786 |
(0.0009) | (0.9997 - 1.0) | (0.0032) | (0.9997 - 1.0) | ||
HPV positive with colp normal | 0.9987 | 0.9999 | 0.9994 | 1.0 | 0.2892 |
(0.0009) | (0.9997 - 1.0) | (0.0003) | (0.9998 - 1.0) | ||
Treated genital warts | 0.9983 | 0.9998 | 0.9957 | 0.9999 | 0.8211 |
(0.0010) | (0.9994 - 1.0) | ( 0.0034) | (0.9997 - 1.0) | ||
HG cyto with CIN 1 | 0.9989 | 0.9999 | 0.9922 | 0.9998 | 0.8517 |
(0.0007) | (0.9996 - 0.9999) | (0.0045) | ( 0.9997 - 1.0) | ||
HG cyt with CIN 2 or 3 | 0.9983 | 0.9997 | 0.9954 | 0.9999 | 0.8733 |
(0.0010) | (0.9994 - 0.9998) | (0.0033) | (0.9992 - 1.0) | ||
Early stage cervical cancer | 0.9732 | 0.9950 | 0.9697 | 0.9850 | 0.4817 |
(0.0085) | (0.9550 - 0.9950) | (0.0066) | (0.9450 - 0.9950) | ||